DOI: 10.1128/IAI.00607-20
Article Information
PubMed
Published By
History
- Received October 1, 2020
- Returned for modification October 24, 2020
- Accepted December 1, 2020
- Published online February 16, 2021.
Copyright & Usage
Copyright © 2021 Wolf et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
Editors and / or Reviewers
- Guy H. Palmer, Editor, Washington State University
Article Versions
- Accepted Manuscript version (December 14, 2020).
- You are viewing the most recent version of this article.
Author Information
- Address correspondence to F. Heath Damron, fdamron{at}hsc.wvu.edu.
↵* Present address: Dylan T. Boehm, Vaccine and Gene Therapy Institute at Oregon Health Sciences University, Beaverton, Oregon, USA.
M. Allison Wolf and Dylan T. Boehm contributed equally to this work. Author order was determined based on contribution and authorship of manuscript.
Citation Wolf MA, Boehm DT, DeJong MA, Wong TY, Sen-Kilic E, Hall JM, Blackwood CB, Weaver KL, Kelly CO, Kisamore CA, Bitzer GJ, Bevere JR, Barbier M, Damron FH. 2021. Intranasal immunization with acellular pertussis vaccines results in long-term immunity to Bordetella pertussis in mice. Infect Immun 89:e00607-20. https://doi.org/10.1128/IAI.00607-20.
